Sign inJoin waitlistJoin the waitlist

Laura Goff

Executive Medical Director, Cancer Patient Care Center · Vanderbilt University Medical Center

Credentials: · · · ·

History

Cancer Patient Care Center · Vanderbilt University Medical Center
Present
Vanderbilt University Medical Center
Present

Vanderbilt University Medical Center
2005–2007
Internal Medicine
University of Texas Southwestern Medical Center
2001–2004
University of Texas School of Medicine at San Antonio
1997–2001

Research

NCCN clinical practice guidelines in oncology: hepatobiliary cancers
Journal of the National Comprehensive Cancer Network · 2009 · 526 citations
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline
Journal of Clinical Oncology · 2020 · 478 citations
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update
Journal of Clinical Oncology · 2024 · 263 citations

Jordan Berlin
23 papers
Dana Cardin
14 papers
Kristen Ciombor
9 papers · 2 as a fellow
Kate Kelley
6 papers
Rajiv Agarwal
6 papers
Thatcher Heumann
6 papers
EC
Emily Chan
5 papers
SD
Satya Das
5 papers · 2 as a fellow
AZ
Andrew Zhu
4 papers
GA
Ghassan Abou-Alfa
4 papers
Kristen Spencer
4 papers
Lipika Goyal
4 papers

Clinical trials

Alisertib and Combination Chemotherapy in Treating Patients With Gastrointestinal Tumors
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
2015–2018
Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
Principal investigator · Completed · Phase 1
Vanderbilt-Ingram Cancer Center
2009–2016
Pharmacogenomically Selected Treatment for Gastric and Gastroesophageal Junction (GEJ) Tumors
Principal investigator · Completed · Phase 2
Vanderbilt University
2007–2013
Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
Principal investigator · Completed · Phase 1
National Cancer Institute (NCI)
2007–2013